1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Gastro-oesophageal reflux, including Barrett's oesophagus

Cytosponge for detecting abnormal cells in the oesophagus

Medtech innovation briefing [MIB240] Published: 15 December 2020

  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing
Download (PDF)

Advice

  • 2 NICE interactive flowcharts
    • Dyspepsia and gastro-oesophageal reflux disease
    • Suspected cancer recognition and referral
  • Next

NICE has developed a medtech innovation briefing (MIB) on Cytosponge for detecting abnormal cells in the oesophagus.

What are MIBs?


  • Next